SCHEMBL4849331

SCHEMBL4849331

COc1ccc(CN(C)C)c(/C=C/C(=O)c2cc(-c3ccccc3C)ccc2OCCN(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 2/20 0.42
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TNFRSF1A P19438 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.39
ESR1 P03372 1/20 0.38
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6141493 1.00 SLC6A9 (0.42) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4845759 0.91 ABCG2 (0.47) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4854857 0.91 ABCG2 (0.47) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4849336 0.91 TNFRSF1A (0.44) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4853568 0.90 SLC6A9 (0.46) SLC6A9SMN1; SMN2ESR1BCHEACHE
SCHEMBL4847435 0.90 SLC6A9 (0.46) SLC6A9SMN1; SMN2ESR1BCHEACHE
SCHEMBL4852348 0.87 SLC6A9 (0.45) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4856317 0.87 ABCG2 (0.46) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4848486 0.87 SLC6A9 (0.45) SLC6A9PDE4APDE4BPDE4CPDE4D
SCHEMBL4848031 0.87 ABCG2 (0.46) SLC6A9PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed